Overview
- 6 FDA inspections are on record.
- 6 inspections produced a Form 483.
- The most recent recorded inspection date is 2026-03-25.
At a glance
Inspections
6
Form 483s
6
EIRs
1
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 16 Mar 2026 – 25 Mar 2026 | Biologics | 483 | View 483 → |
| 2 Aug 2023 – 10 Aug 2023 | Biologics | 483 | View 483 → |
| 28 Oct 2019 – 8 Nov 2019 | Biologics | 483 | View 483 → |
| 9 Jan 2018 – 19 Jan 2018 | Biologics | 483 | View 483 → |
| 14 Jan 2016 – 22 Jan 2016 | Biologics | 483 | On file |
| 8 Apr 2011 | Not recorded | 483 | On file |
Observations on record
Form 483 observations cited at this site, most recent first.
Control procedures to monitor and validate performance
Cited by Sony Mathews, Esther A Ofori, Emily B Camire, Lizaida Perez
Procedures for sterile drug products
Cited by Sony Mathews, Esther A Ofori, Emily B Camire, Lizaida Perez
Reprocessing/quality control unit
Cited by Sony Mathews, Esther A Ofori, Emily B Camire, Lizaida Perez
Batch production and Batch Control Record Requirements
Cited by Sony Mathews, Esther A Ofori, Emily B Camire, Lizaida Perez
Written record of investigation incomplete
Cited by Sony Mathews, Esther A Ofori, Emily B Camire, Lizaida Perez
Investigators
FDA investigators tied to this site in the record.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 6x |
| 21 CFR 211.113(b) | Cited across public-safe Form 483 observations | 5x |
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.101(d) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.142 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.188(b)(7) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.42(c)(1) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.42(c)(2) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.46(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.67(b)(2) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 600.80(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.115(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.122(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a)(4) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a)(8) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.25(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.84(e) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.94(a) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Dendreon Pharmaceuticals LLC's 6 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat